Skip to main content
Signal8

Von Koch Thomas

SEC insider (Form 3/4/5 filer). CIK 0001938915. 10% Owner at DiaMedica Therapeutics Inc. (DMAC). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 23, 2025. Located in STOCKHOLM, V7.

Companies Von Koch Thomas has filed insider reports for

  • DiaMedica Therapeutics Inc. (DMAC): 10% Owner
Von Koch Thomas profile photo

Von Koch Thomas

CIK: 0001938915

Transaction Breakdown

Open Market Buys (P)1 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DiaMedica Therapeutics Inc. logo
DMAC

DiaMedica Therapeutics Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • DiaMedica Therapeutics Inc. logo
    DMAC

    DiaMedica Therapeutics Inc.

    Jul 23, 2025
    Purchase
    Indirect
    2.9M shares at avg. $3.50$10.0M

1-1 of 1